NO313486B1 - Hurtignedbrytbar medikamentform av tramadol eller et tramadolsalt - Google Patents

Hurtignedbrytbar medikamentform av tramadol eller et tramadolsalt Download PDF

Info

Publication number: NO313486B1
Authority: NO; Norway
Prior art keywords: tramadol; tablets; salt; starch; water
Prior art date: 1995-08-19

Application number

NO19963430A

Other languages

English (en)

Norwegian (no)

Other versions

NO963430D0 (no

NO963430L (no

Inventor

Juergen Betzing

Johannes Heinich Bartholomaeus

Original Assignee

Gruenenthal Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-08-19

Filing date

1996-08-16

Publication date

2002-10-14

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7769912&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO313486(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1996-08-16 Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh

1996-08-16 Publication of NO963430D0 publication Critical patent/NO963430D0/no

1997-02-20 Publication of NO963430L publication Critical patent/NO963430L/no

2002-10-14 Publication of NO313486B1 publication Critical patent/NO313486B1/no

Links

TVYLLZQTGLZFBW-ZBFHGGJFSA-N (R,R)-tramadol Chemical compound COC1=CC=CC([C@]2(O)[C@H](CCCC2)CN(C)C)=C1 TVYLLZQTGLZFBW-ZBFHGGJFSA-N 0.000 title claims description 28
229960004380 tramadol Drugs 0.000 title claims description 13
TVYLLZQTGLZFBW-GOEBONIOSA-N tramadol Natural products COC1=CC=CC([C@@]2(O)[C@@H](CCCC2)CN(C)C)=C1 TVYLLZQTGLZFBW-GOEBONIOSA-N 0.000 title claims description 13
229940079593 drug Drugs 0.000 title description 6
239000003814 drug Substances 0.000 title description 6
229920002472 Starch Polymers 0.000 claims description 19
235000019698 starch Nutrition 0.000 claims description 19
239000008107 starch Substances 0.000 claims description 18
229920000168 Microcrystalline cellulose Polymers 0.000 claims description 11
229940016286 microcrystalline cellulose Drugs 0.000 claims description 11
235000019813 microcrystalline cellulose Nutrition 0.000 claims description 11
239000008108 microcrystalline cellulose Substances 0.000 claims description 11
239000002360 explosive Substances 0.000 claims description 8
239000003826 tablet Substances 0.000 description 59
230000015556 catabolic process Effects 0.000 description 22
235000019589 hardness Nutrition 0.000 description 17
239000004480 active ingredient Substances 0.000 description 14
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 14
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 10
HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 10
238000006731 degradation reaction Methods 0.000 description 8
PPKXEPBICJTCRU-XMZRARIVSA-N (R,R)-tramadol hydrochloride Chemical compound Cl.COC1=CC=CC([C@]2(O)[C@H](CCCC2)CN(C)C)=C1 PPKXEPBICJTCRU-XMZRARIVSA-N 0.000 description 7
229960003107 tramadol hydrochloride Drugs 0.000 description 7
WINXNKPZLFISPD-UHFFFAOYSA-M Saccharin sodium Chemical compound [Na+].C1=CC=C2C(=O)[N-]S(=O)(=O)C2=C1 WINXNKPZLFISPD-UHFFFAOYSA-M 0.000 description 6
239000000126 substance Substances 0.000 description 6
244000246386 Mentha pulegium Species 0.000 description 5
235000016257 Mentha pulegium Nutrition 0.000 description 5
235000004357 Mentha x piperita Nutrition 0.000 description 5
235000007265 Myrrhis odorata Nutrition 0.000 description 5
240000004760 Pimpinella anisum Species 0.000 description 5
235000012550 Pimpinella anisum Nutrition 0.000 description 5
239000011230 binding agent Substances 0.000 description 5
235000001050 hortel pimenta Nutrition 0.000 description 5
235000019359 magnesium stearate Nutrition 0.000 description 5
239000000203 mixture Substances 0.000 description 5
238000003825 pressing Methods 0.000 description 5
239000000377 silicon dioxide Substances 0.000 description 5
235000012239 silicon dioxide Nutrition 0.000 description 5
229920002261 Corn starch Polymers 0.000 description 4
239000008120 corn starch Substances 0.000 description 4
229940099112 cornstarch Drugs 0.000 description 4
FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 3
229930195725 Mannitol Natural products 0.000 description 3
239000000594 mannitol Substances 0.000 description 3
235000010355 mannitol Nutrition 0.000 description 3
238000004519 manufacturing process Methods 0.000 description 3
239000002609 medium Substances 0.000 description 3
239000002245 particle Substances 0.000 description 3
239000000546 pharmaceutical excipient Substances 0.000 description 3
229920002785 Croscarmellose sodium Polymers 0.000 description 2
102000004190 Enzymes Human genes 0.000 description 2
108090000790 Enzymes Proteins 0.000 description 2
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
238000005422 blasting Methods 0.000 description 2
FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 2
239000001768 carboxy methyl cellulose Substances 0.000 description 2
235000019700 dicalcium phosphate Nutrition 0.000 description 2
230000001079 digestive effect Effects 0.000 description 2
239000007884 disintegrant Substances 0.000 description 2
230000000694 effects Effects 0.000 description 2
239000000945 filler Substances 0.000 description 2
235000011389 fruit/vegetable juice Nutrition 0.000 description 2
239000004615 ingredient Substances 0.000 description 2
239000008101 lactose Substances 0.000 description 2
229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
230000008092 positive effect Effects 0.000 description 2
239000007787 solid Substances 0.000 description 2
239000000725 suspension Substances 0.000 description 2
RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
108010011485 Aspartame Proteins 0.000 description 1
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
UDIPTWFVPPPURJ-UHFFFAOYSA-M Cyclamate Chemical compound [Na+].[O-]S(=O)(=O)NC1CCCCC1 UDIPTWFVPPPURJ-UHFFFAOYSA-M 0.000 description 1
108010010803 Gelatin Proteins 0.000 description 1
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
229920003085 Kollidon® CL Polymers 0.000 description 1
244000269722 Thea sinensis Species 0.000 description 1
DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical class [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
239000000783 alginic acid Substances 0.000 description 1
235000010443 alginic acid Nutrition 0.000 description 1
229920000615 alginic acid Polymers 0.000 description 1
229960001126 alginic acid Drugs 0.000 description 1
150000004781 alginic acids Chemical class 0.000 description 1
230000000202 analgesic effect Effects 0.000 description 1
239000012736 aqueous medium Substances 0.000 description 1
239000000605 aspartame Substances 0.000 description 1
235000010357 aspartame Nutrition 0.000 description 1
IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
229960003438 aspartame Drugs 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
239000008280 blood Substances 0.000 description 1
210000004369 blood Anatomy 0.000 description 1
239000007853 buffer solution Substances 0.000 description 1
239000011575 calcium Substances 0.000 description 1
229960005069 calcium Drugs 0.000 description 1
229910052791 calcium Inorganic materials 0.000 description 1
YYRMJZQKEFZXMX-UHFFFAOYSA-L calcium bis(dihydrogenphosphate) Chemical compound [Ca+2].OP(O)([O-])=O.OP(O)([O-])=O YYRMJZQKEFZXMX-UHFFFAOYSA-L 0.000 description 1
229940062672 calcium dihydrogen phosphate Drugs 0.000 description 1
229910000389 calcium phosphate Inorganic materials 0.000 description 1
235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
239000008112 carboxymethyl-cellulose Substances 0.000 description 1
235000010980 cellulose Nutrition 0.000 description 1
229920002678 cellulose Polymers 0.000 description 1
239000001913 cellulose Substances 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
238000003776 cleavage reaction Methods 0.000 description 1
239000000625 cyclamic acid and its Na and Ca salt Substances 0.000 description 1
238000009792 diffusion process Methods 0.000 description 1
238000004090 dissolution Methods 0.000 description 1
238000009826 distribution Methods 0.000 description 1
239000013583 drug formulation Substances 0.000 description 1
235000013399 edible fruits Nutrition 0.000 description 1
239000007938 effervescent tablet Substances 0.000 description 1
230000037406 food intake Effects 0.000 description 1
235000003599 food sweetener Nutrition 0.000 description 1
210000004051 gastric juice Anatomy 0.000 description 1
229920000159 gelatin Polymers 0.000 description 1
235000019322 gelatine Nutrition 0.000 description 1
235000011852 gelatine desserts Nutrition 0.000 description 1
239000008187 granular material Substances 0.000 description 1
239000003979 granulating agent Substances 0.000 description 1
239000007788 liquid Substances 0.000 description 1
229940031703 low substituted hydroxypropyl cellulose Drugs 0.000 description 1
239000000314 lubricant Substances 0.000 description 1
235000019691 monocalcium phosphate Nutrition 0.000 description 1
238000004806 packaging method and process Methods 0.000 description 1
239000001267 polyvinylpyrrolidone Substances 0.000 description 1
239000003755 preservative agent Substances 0.000 description 1
230000007017 scission Effects 0.000 description 1
239000011734 sodium Substances 0.000 description 1
229910052708 sodium Inorganic materials 0.000 description 1
235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
229960001462 sodium cyclamate Drugs 0.000 description 1
230000003595 spectral effect Effects 0.000 description 1
235000013599 spices Nutrition 0.000 description 1
238000003756 stirring Methods 0.000 description 1
238000006467 substitution reaction Methods 0.000 description 1
239000003765 sweetening agent Substances 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Pain & Pain Management (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Neurosurgery (AREA)
Zoology (AREA)
Nutrition Science (AREA)
Physiology (AREA)
Rheumatology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Cosmetics (AREA)

NO19963430A 1995-08-19 1996-08-16 Hurtignedbrytbar medikamentform av tramadol eller et tramadolsalt NO313486B1 (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE19530575A DE19530575A1 (de)	1995-08-19	1995-08-19	Schnell zerfallende Arzneiform von Tramadol oder einem Tramadolsalz

Publications (3)

Publication Number	Publication Date
NO963430D0 NO963430D0 (no)	1996-08-16
NO963430L NO963430L (no)	1997-02-20
NO313486B1 true NO313486B1 (no)	2002-10-14

Family

ID=7769912

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO19963430A NO313486B1 (no)	1995-08-19	1996-08-16	Hurtignedbrytbar medikamentform av tramadol eller et tramadolsalt

Country Status (28)

Country	Link
US (1)	US5776492A (fr)
EP (1)	EP0759296B1 (fr)
JP (1)	JP4074675B2 (fr)
CN (1)	CN1102385C (fr)
AR (1)	AR003476A1 (fr)
AT (1)	ATE205708T1 (fr)
AU (1)	AU703310B2 (fr)
BR (1)	BR9604034A (fr)
CA (1)	CA2182939C (fr)
CZ (1)	CZ289167B6 (fr)
DE (2)	DE19530575A1 (fr)
DK (1)	DK0759296T3 (fr)
ES (1)	ES2164198T3 (fr)
GR (1)	GR3036720T3 (fr)
HU (1)	HU227360B1 (fr)
IL (1)	IL119080A (fr)
MY (1)	MY113908A (fr)
NO (1)	NO313486B1 (fr)
NZ (1)	NZ299141A (fr)
PE (1)	PE8298A1 (fr)
PL (1)	PL184785B1 (fr)
PT (1)	PT759296E (fr)
RU (1)	RU2174837C2 (fr)
SI (1)	SI0759296T1 (fr)
SK (1)	SK281779B6 (fr)
UA (1)	UA41392C2 (fr)
UY (1)	UY24308A1 (fr)
ZA (1)	ZA966985B (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN100389752C (zh) *	1978-04-21	2008-05-28	莱博法姆公司	控释组合物
CA2217238C (fr) *	1997-10-24	2005-09-20	Louis Cartilier	Cellulose reticulee employee comme excipient de comprimes
DE69901938T3 (de) *	1998-03-06	2012-08-02	Aptalis Pharma S.R.L.	Schnell zerfallende tablette
SE9802973D0 (sv) *	1998-09-03	1998-09-03	Astra Ab	Immediate release tablet
DE19901683B4 (de) *	1999-01-18	2005-07-21	Grünenthal GmbH	Analgetikum mit kontrollierter Wirkstofffreisetzung
DE19901686A1 (de) *	1999-01-18	2000-07-20	Gruenenthal Gmbh	Retardierte Tramadolzubereitungen mit einem lagerstabilen Freisetzungsprofil und Verfahren zu deren Herstellung
GB9904911D0 (en) *	1999-03-03	1999-04-28	Scherer Ltd R P	Pharmaceutical compositions
KR20020031419A (ko) *	1999-08-31	2002-05-01	파퀘스, 파우쓰-베르구스	트라마돌 사카리네이트를 함유하는 지효성 투여형
MXPA02002193A (es) *	1999-08-31	2002-09-30	Gr Nenthal Gmbh	Forma de administracion de accion retardada que contiene sacarinato de tramadol.
DE19940740A1 (de) *	1999-08-31	2001-03-01	Gruenenthal Gmbh	Pharmazeutische Salze
DE19940944B4 (de) *	1999-08-31	2006-10-12	Grünenthal GmbH	Retardierte, orale, pharmazeutische Darreichungsformen
RU2174836C1 (ru) *	2000-12-15	2001-10-20	Открытое акционерное общество "Химико-фармацевтический комбинат "Акрихин"	Фармацевтическая композиция, обладающая анальгезирующим действием
TWI319713B (en)	2002-10-25	2010-01-21		Sustained-release tramadol formulations with 24-hour efficacy
WO2004037222A2 (fr) *	2002-10-25	2004-05-06	Labopharm Inc.	Preparations de tramadol a liberation soutenue dotees d'une efficacite de 24 heures
CN1942175B (zh) *	2002-10-25	2010-05-26	莱博法姆公司	24小时有效的曲马多缓释制剂
DK1558935T3 (da) *	2002-10-25	2008-11-17	Labopharm Inc	Præparater med styret afgivelse
US8487002B2 (en)	2002-10-25	2013-07-16	Paladin Labs Inc.	Controlled-release compositions
US20040265375A1 (en) *	2003-04-16	2004-12-30	Platteeuw Johannes J.	Orally disintegrating tablets
ES2401769T5 (es)	2003-09-12	2020-07-01	Amgen Inc	Formulación de disolución rápida de cinacalcet HCl
US20060172006A1 (en) *	2003-10-10	2006-08-03	Vincent Lenaerts	Sustained-release tramadol formulations with 24-hour clinical efficacy
ES2255429B1 (es) *	2004-10-25	2007-08-16	Italfarmaco, S.A.	Composiciones farmaceuticas bucodispersables.
US8022053B2 (en) *	2004-11-02	2011-09-20	Bayer Schering Pharma Aktiengesellschaft	Oral solid dosage forms containing a low dose of estradiol
RU2008113439A (ru)	2005-09-09	2009-10-20	Лабофарм Инк. (CA)	Композиции с замедленным высвобождением лекарственного средства
EA014739B1 (ru)	2005-09-09	2011-02-28	Лабофарм Инк.	Композиция тразодона для введения один раз в день
US20090004248A1 (en) *	2007-06-29	2009-01-01	Frank Bunick	Dual portion dosage lozenge form
ITMI20130210A1 (it)	2013-02-14	2014-08-15	Menarini Lab	Composizioni farmaceutiche contenenti dexketoprofene e tramadolo

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3181998A (en)	1960-08-12	1965-05-04	Joseph L Kanig	Tablet disintegration
DE1617343B2 (de)	1967-04-21	1976-04-22	CH. Boehringer Sohn, 6507 Ingelheim	Traegermasse fuer arzneimitteltabletten
US4517179A (en)	1983-04-29	1985-05-14	Pennwalt Corporation	Rapid dissolving, uniform drug compositions and their preparation
US4600579A (en)	1983-06-07	1986-07-15	Mallinckrodt, Inc.	N-acetyl-p-aminophenol compositions containing partially gelatinized starch and method for preparing same
EP0147780A3 (fr) *	1984-01-03	1987-03-11	Merck & Co. Inc.	Dispositif pour la libération d'un médicament
JPH0830005B2 (ja)	1985-09-25	1996-03-27	ゲルゲリイ、ゲルハルト	崩壊性錠剤とその製造方法
US5211957A (en) *	1988-03-25	1993-05-18	Ciba-Geigy Corporation	Solid rapidly disintegrating dosage form
CH675537A5 (fr)	1988-03-25	1990-10-15	Ciba Geigy Ag
US5254355A (en)	1992-05-29	1993-10-19	Kraft General Foods, Inc.	Process for beverage tablets and products therefrom
DE4329794C2 (de) *	1993-09-03	1997-09-18	Gruenenthal Gmbh	Tramadolsalz enthaltende Arzneimittel mit verzögerter Wirkstofffreisetzung

1995
- 1995-08-19 DE DE19530575A patent/DE19530575A1/de not_active Withdrawn
1996
- 1996-05-29 MY MYPI96002047A patent/MY113908A/en unknown
- 1996-07-17 PT PT96111483T patent/PT759296E/pt unknown
- 1996-07-17 DK DK96111483T patent/DK0759296T3/da active
- 1996-07-17 DE DE59607710T patent/DE59607710D1/de not_active Revoked
- 1996-07-17 SI SI9630318T patent/SI0759296T1/xx unknown
- 1996-07-17 EP EP96111483A patent/EP0759296B1/fr not_active Revoked
- 1996-07-17 ES ES96111483T patent/ES2164198T3/es not_active Expired - Lifetime
- 1996-07-17 AT AT96111483T patent/ATE205708T1/de not_active IP Right Cessation
- 1996-07-30 BR BR9604034A patent/BR9604034A/pt not_active Application Discontinuation
- 1996-08-06 AU AU61941/96A patent/AU703310B2/en not_active Ceased
- 1996-08-07 CN CN96110917A patent/CN1102385C/zh not_active Expired - Fee Related
- 1996-08-08 CA CA002182939A patent/CA2182939C/fr not_active Expired - Fee Related
- 1996-08-08 NZ NZ299141A patent/NZ299141A/en not_active IP Right Cessation
- 1996-08-09 SK SK1042-96A patent/SK281779B6/sk not_active IP Right Cessation
- 1996-08-09 JP JP21122196A patent/JP4074675B2/ja not_active Expired - Fee Related
- 1996-08-09 CZ CZ19962359A patent/CZ289167B6/cs not_active IP Right Cessation
- 1996-08-09 PE PE1996000597A patent/PE8298A1/es not_active Application Discontinuation
- 1996-08-12 AR ARP960103957A patent/AR003476A1/es not_active Application Discontinuation
- 1996-08-14 UY UY24308A patent/UY24308A1/es not_active IP Right Cessation
- 1996-08-14 PL PL96315749A patent/PL184785B1/pl not_active IP Right Cessation
- 1996-08-16 ZA ZA9606985A patent/ZA966985B/xx unknown
- 1996-08-16 RU RU96116411/14A patent/RU2174837C2/ru not_active IP Right Cessation
- 1996-08-16 IL IL11908096A patent/IL119080A/en not_active IP Right Cessation
- 1996-08-16 NO NO19963430A patent/NO313486B1/no not_active IP Right Cessation
- 1996-08-16 HU HU9602266A patent/HU227360B1/hu not_active IP Right Cessation
- 1996-08-19 US US08/699,623 patent/US5776492A/en not_active Expired - Lifetime
- 1996-08-19 UA UA96083292A patent/UA41392C2/uk unknown
2001
- 2001-09-26 GR GR20010401577T patent/GR3036720T3/el not_active IP Right Cessation

Also Published As

Publication number	Publication date
SK104296A3 (en)	1997-05-07
SK281779B6 (sk)	2001-07-10
AU703310B2 (en)	1999-03-25
NO963430D0 (no)	1996-08-16
HU227360B1 (en)	2011-04-28
EP0759296B1 (fr)	2001-09-19
US5776492A (en)	1998-07-07
ZA966985B (en)	1997-02-24
NZ299141A (en)	1997-12-19
NO963430L (no)	1997-02-20
IL119080A0 (en)	1996-11-14
BR9604034A (pt)	1998-06-09
AU6194196A (en)	1997-02-27
MY113908A (en)	2002-06-30
HK1010100A1 (en)	1999-06-11
ATE205708T1 (de)	2001-10-15
EP0759296A1 (fr)	1997-02-26
HU9602266D0 (en)	1996-10-28
PE8298A1 (es)	1998-03-28
CA2182939C (fr)	2007-06-19
UY24308A1 (es)	1996-08-27
CN1145780A (zh)	1997-03-26
JP4074675B2 (ja)	2008-04-09
DK0759296T3 (da)	2001-11-26
PL315749A1 (en)	1997-03-03
GR3036720T3 (en)	2001-12-31
HUP9602266A3 (en)	1998-10-28
MX9603140A (es)	1997-07-31
HUP9602266A2 (en)	1997-12-29
IL119080A (en)	2001-07-24
CZ235996A3 (en)	1997-02-12
CA2182939A1 (fr)	1997-02-20
CZ289167B6 (cs)	2001-11-14
DE59607710D1 (de)	2001-10-25
SI0759296T1 (fr)	2001-12-31
CN1102385C (zh)	2003-03-05
PL184785B1 (pl)	2002-12-31
PT759296E (pt)	2002-03-28
ES2164198T3 (es)	2002-02-16
JPH09110684A (ja)	1997-04-28
UA41392C2 (uk)	2001-09-17
DE19530575A1 (de)	1997-02-20
RU2174837C2 (ru)	2001-10-20
AR003476A1 (es)	1998-08-05

Legal Events

Date	Code	Title	Description
2014-03-24	MM1K	Lapsed by not paying the annual fees

Publication	Publication Date	Title
RU2174837C2 (ru)	2001-10-20	Быстрораспадающаяся готовая препаративная форма трамадола или соли трамадола
KR100477293B1 (ko)	2005-03-17	플래쉬-용융 경구 투여 제형
US6358526B1 (en)	2002-03-19	Method of making tablets and tablet compositions produced therefrom
US20060099250A1 (en)	2006-05-11	Use of an aqueous solution of citric acid and a water-soluble sugar like lactitol as granulation liquid in the manufacture of tablets
CN111432840A (zh)	2020-07-17	固体经口烟碱制剂
FR2824477A1 (fr)	2002-11-15	Granules enrobes a base d'inhibiteur de l'enzyme de conversion de l'anfiotensine, leur procede de preparation et comprimes orodispersibles contenant les granules enrobes
US20240000706A1 (en)	2024-01-04	Compressed nicotine lozenge
WO2007086457A1 (fr)	2007-08-02	Comprimé à désagrégation rapide produit par pastillage direct à sec
EA010972B1 (ru)	2008-12-30	Композиция, содержащая смесь активных начал, и способ ее получения
NO326259B1 (no)	2008-10-27	Faste oralt-dispergerbare farmasoytiske formuleringer
US20110150993A1 (en)	2011-06-23	Fine Particle Croscarmellose and Uses Thereof
WO2004089343A1 (fr)	2004-10-21	Comprimes hydrosolubles
US20060147516A1 (en)	2006-07-06	Taste masking system for alprazolam
EP2445486B1 (fr)	2017-11-08	Comprimés d'ibuprofène sodique et procédés de fabrication de compositions pharmaceutiques comprenant de l'ibuprofène sodique
EP0975337B1 (fr)	2003-05-14	Tablettes de flurbiprofen a liberation rapide
RU2818242C2 (ru)	2024-04-26	Продукт в виде пакетика с жидкой композицией вкусовой добавки
MXPA96003140A (en)	1997-12-01	Rapid desintegration medicine based on detramadol or a trama salt
HK1010100B (en)	2002-04-12	Rapidly disintegrating formulation comprising tramadol or a tramadol salt
CN101744820A (zh)	2010-06-23	包含氢溴酸右美沙芬的药物组合物
AU2014200704B2 (en)	2015-09-03	Sodium ibuprofen tablets and methods of manufacturing pharmaceutical compositions including sodium ibuprofen
Kolli et al.	2016	Formulation and evaluation of matrix tablet of ramipril
HK1107522B (en)	2009-10-09	Taste masking system for non-plasticizing drugs